A randomised, double-blind placebo-controlled study assessing the short-term effect of a dermatophagoides pteronyssinus extract, quantified in mass units, in subjects with perennial mite induced asthma

Trial Profile

A randomised, double-blind placebo-controlled study assessing the short-term effect of a dermatophagoides pteronyssinus extract, quantified in mass units, in subjects with perennial mite induced asthma

Completed
Phase of Trial: Phase IV

Latest Information Update: 02 Jun 2011

At a glance

  • Drugs House dust mite allergy immunotherapy (Primary)
  • Indications Allergic asthma
  • Focus Therapeutic Use
  • Sponsors ALK-Abello
  • Most Recent Events

    • 15 Oct 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 11 Mar 2008 The expected completion date for this trial is now 1 May 2008 as reported by ClinicalTrials.gov.
    • 06 Jul 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top